Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Sigma-Aldrich; Cyntellect; MIT

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich has launched a new life sciences brand platform in an effort to "elevate the company's current focus on biology and provide a single destination where researchers can access" biological knowledge, products, and technologies, the firm said in a statement this week. The new "Where Bio Begins" brand is meant to bring attention to the firm's biology focus.


Cyntellect will provide researchers at Harvard University and the Howard Hughes Medical Institute with its Leap Cell Processing Workstation. The researchers will work with Cyntellect's Stem Cell Manager on the Leap Workstation for projects aimed at selectively processing stem cells to "define the factors and mechanisms that regulate the migration, expansion, and regenerative potential of adult blood-forming and muscle-forming stem cells."


The David H. Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology has received funding from the National cancer Institute to become a Center for Cancer Systems Biology. The MIT institute is one of 11 to be named centers. It did not disclose the amount of funding it received from NCI.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.